216 related articles for article (PubMed ID: 9463585)
1. Thymic epithelial tumor progression in an SV40T transgenic mouse model. Cortical thymoma-thymic carcinoma sequence.
Lee SS; Park WY; Chi JG; Seo JW; Kim JI; Kim CW; Park SH; Khang SK; Cho KJ; Seo JS; Jang JJ
Virchows Arch; 1998 Jan; 432(1):33-42. PubMed ID: 9463585
[TBL] [Abstract][Full Text] [Related]
2. Thymoma. Histologic subclassification is an independent prognostic factor.
Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H
Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177
[TBL] [Abstract][Full Text] [Related]
4. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
Kuo TT; Chan JK
Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
[TBL] [Abstract][Full Text] [Related]
5. Thymic epithelial neoplasms in transgenic mice expressing SV40 T antigen under the control of an erythroid-specific enhancer.
Teitz T; Chang JC; Kan YW; Yen TS
J Pathol; 1995 Nov; 177(3):309-15. PubMed ID: 8551394
[TBL] [Abstract][Full Text] [Related]
6. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
[TBL] [Abstract][Full Text] [Related]
7. PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Müller-Hermelink classification. An immunohistochemical study using catalyzed signal amplification.
Hattori H; Tateyama H; Tada T; Saito Y; Yamakawa Y; Eimoto T
Virchows Arch; 2000 Jan; 436(1):20-7. PubMed ID: 10664158
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
Dorfman DM; Shahsafaei A; Miyauchi A
Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of Mcl-1 and bcl-2 proteins in thymic epithelial tumours.
Chen FF; Yan JJ; Chang KC; Lai WW; Chen RM; Jin YT
Histopathology; 1996 Dec; 29(6):541-7. PubMed ID: 8971561
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of tumour-related genes in thymic epithelial tumours.
Hirose Y; Kondo K; Takizawa H; Nagao T; Nakagawa Y; Fujino H; Toba H; Kenzaki K; Sakiyama S; Tangoku A
Lung Cancer; 2009 May; 64(2):155-9. PubMed ID: 18778870
[TBL] [Abstract][Full Text] [Related]
11. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
[TBL] [Abstract][Full Text] [Related]
13. Malignant grading of cortical and medullary differentiated thymoma by morphometric analysis.
Nomori H; Ishihara T; Torikata C
Cancer; 1989 Oct; 64(8):1694-9. PubMed ID: 2676138
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratins in normal thymus and thymic epithelial tumors.
Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
[TBL] [Abstract][Full Text] [Related]
15. Pathological aspects of malignant and benign thymic disorders.
Müller-Hermelink HK; Marx A
Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic features in thymic epithelial tumors.
Kirchner T; Schalke B; Marx A; Müller-Hermelink HK
Thymus; 1989; 14(1-3):195-203. PubMed ID: 2623740
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological correlation of epithelial subtyping in thymoma: a study of 112 consecutive cases.
Pan CC; Wu HP; Yang CF; Chen WY; Chiang H
Hum Pathol; 1994 Sep; 25(9):893-9. PubMed ID: 8088764
[TBL] [Abstract][Full Text] [Related]
18. Thymic epithelial neoplasms with sebaceous differentiation: a clinicopathological and immunohistochemical study of 8 cases.
Kalhor N; Moran CA
Hum Pathol; 2019 Apr; 86():124-128. PubMed ID: 30537491
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
Li H; Ren B; Yu S; Gao H; Sun PL
BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
[TBL] [Abstract][Full Text] [Related]
20. Thymic tumours in Denmark. A retrospective study of 213 cases from 1970-1993.
Engel P; Marx A; Müller-Hermelink HK
Pathol Res Pract; 1999; 195(8):565-70. PubMed ID: 10483587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
